InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Bhatt Nailesh, 董事. Director active across 2 companies, notably Sonnet BioTherapeutics Holdings, Inc.. In total, 10 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €5k. History available since 17 May 2023. The latest transaction was disclosed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Bhatt Nailesh is an Administrateur at Sonnet BioTherapeutics Holdings, Inc. and Hyperliquid Strategies Inc. The declarant has 10 filings in total, and across the 10 recent filings we hold, the reported buy volume is EUR 5351 and the reported sell volume is EUR 0, with filings dated from 2022-04-08 to 2026-07-06. The most frequent transaction nature is Attribution.